BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3832120)

  • 1. Human chorionic gonadotropin-positive seminoma: is this a special type of seminoma with a poor prognosis?
    Scheiber K; Mikuz G; Frommhold H; Bartsch G
    Prog Clin Biol Res; 1985; 203():97-104. PubMed ID: 3832120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No predictive value of beta-hCG in patients with stage I seminoma--results of a long-term follow-up study after adjuvant radiotherapy.
    Bruns F; Raub M; Schaefer U; Micke O
    Anticancer Res; 2005; 25(3A):1543-6. PubMed ID: 16033057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical studies of testicular tumor. I. Analysis of 27 patients with seminoma: the clinical significance of hCG-beta determination and of retroperitoneal lymph node dissection for stage I patients].
    Tsukamoto T; Kumamoto Y; Ohmura K; Tsunekawa T; Yamazaki K
    Hinyokika Kiyo; 1986 Jul; 32(7):989-97. PubMed ID: 2430436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical studies of testicular tumor. II. Analysis of 30 patients with nonseminomatous testicular tumor].
    Tsukamoto T; Kumamoto Y; Ohmura K; Tsunekawa T; Yamazaki K
    Hinyokika Kiyo; 1986 Jul; 32(7):999-1011. PubMed ID: 2430437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beta-HCG positive seminoma--incidence with special reference to tumor marker concentration in testicular venous blood].
    Mumperow E; Kressel K; Hartmann M
    Urologe A; 1991 Mar; 30(2):114-6; discussion 117. PubMed ID: 1711727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation therapy: a primary treatment modality for seminoma.
    Stutzman RE; McLeod DG
    Urol Clin North Am; 1980 Oct; 7(3):757-64. PubMed ID: 7456184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HCG-positive cells in seminoma of the testis].
    Gotoh S; Fukui I; Yokokawa M; Aoki N; Kamiyama R
    Hinyokika Kiyo; 1984 Feb; 30(2):169-73. PubMed ID: 6204519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
    Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
    J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of seminoma: does a positive HCG influence prognosis?
    Bartsch G; Mikuz G; Frommhold H; Scheiber K
    Prog Clin Biol Res; 1985; 203():483-4. PubMed ID: 2421340
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pure testicular seminoma. Experience in treatment of 44 patients].
    Vallejo C; Leone B; Rabinovich M; Elem Y; Mingote P; Pereyra E; Losada C; Delpin O
    Medicina (B Aires); 1990; 50(6):521-6. PubMed ID: 2130242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer.
    Javadpour N; McIntire KR; Waldmann TA
    Natl Cancer Inst Monogr; 1978 Dec; (49):209-13. PubMed ID: 86162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of biologic tumor markers in testicular cancer.
    Javadpour N
    Cancer Treat Rep; 1979; 63(9-10):1643-7. PubMed ID: 91433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in seminomas with special respect to HCG: results of a prospective multicenter study. Seminoma Study Group.
    Weissbach L; Bussar-Maatz R; Löhrs U; Schubert GE; Mann K; Hartmann M; Dieckmann KP; Fassbinder J
    Eur Urol; 1999 Dec; 36(6):601-8. PubMed ID: 10559615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical outcome of adult testicular tumor. II. Study on patients with positive human chorionic gonadotropin].
    Sakuramoto T; Kihara K; Kawai T
    Hinyokika Kiyo; 1984 May; 30(5):639-49. PubMed ID: 6089533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
    Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
    J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologically pure stage I seminoma with an elevated beta-hCG of 4497 IU/l.
    Bjurlin MA; August CZ; Weldon-Linne M; Totonchi E
    Urology; 2007 Nov; 70(5):1007.e13-5. PubMed ID: 18068467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical observation of twelve cases of testicular cancer].
    Takemae K; Tajiri S; Suzuki T; Hata S
    Hinyokika Kiyo; 1987 Aug; 33(8):1199-206. PubMed ID: 2447765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of tumor markers in testicular seminomas. Results of a prospective multicenter study.
    Weissbach L; Bussar-Maatz R; Mann K
    Eur Urol; 1997; 32(1):16-22. PubMed ID: 9266226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor markers in testicular cancer].
    Mann K
    Urologe A; 1990 Mar; 29(2):77-86. PubMed ID: 2158684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.